Publications en collaboration avec des chercheurs de University of Göttingen (1)

2015

  1. Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial

    Journal of the American Academy of Dermatology, Vol. 73, Núm. 3, pp. 400-409